Risk of diabetes, hyperlipidemia, and hypertension and the use of atypical antipsychotics in schizophrenia

被引:0
|
作者
Damler, RM
Zhao, Z
Jackson, EA
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S425 / S425
页数:1
相关论文
共 50 条
  • [31] Combined use of atypical antipsychotics and cognitive-behavioural therapy in schizophrenia
    Duggal, HS
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2002, 47 (09): : 887 - 888
  • [32] Use of atypical antipsychotics among VA patients with schizophrenia: National trends
    Blow, FC
    McCarthy, JF
    Valenstein, M
    Smelson, DA
    Reist, C
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 539 - 539
  • [33] Adjunctive use of atypical antipsychotics and anticholinergic drugs among patients with schizophrenia
    Ren, XS
    Huang, YH
    Lee, AF
    Miller, DR
    Qian, S
    Kazis, L
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2005, 30 (01) : 65 - 71
  • [34] Atypical antipsychotics in the treatment of schizophrenia - Reply
    Geddes, J
    Harrison, P
    Freemantle, N
    Bebbington, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7291): : 927 - 928
  • [35] Schizophrenia, weight gain and atypical antipsychotics
    Brown, S
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 : 191 - 192
  • [36] Schizophrenia therapy: beyond atypical antipsychotics
    Eric M. Snyder
    Melanie R. Murphy
    [J]. Nature Reviews Drug Discovery, 2008, 7 : 471 - 472
  • [37] Selection of atypical antipsychotics for the management of schizophrenia
    Sprague, DA
    Loewen, PS
    Raymond, CB
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (02) : 313 - 319
  • [38] Schizophrenia therapy: beyond atypical antipsychotics
    Snyder, Eric M.
    Murphy, Melanie R.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (06) : 471 - 472
  • [39] Atypical antipsychotics in schizophrenia: clinical efficacy
    Verhoeven, WMA
    van der Heijden, FMMA
    Tuinier, S
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2003, 57 (02) : 111 - 111
  • [40] The quality of life in schizophrenia and atypical antipsychotics
    Podea, DM
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S297 - S297